Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06191744
Title Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma (EPCORE™FL-2)
Acronym EPCORE™FL-2
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Fort Wayne Medical Oncology and Hematology- South Office /ID# 259583 RECRUITING Fort Wayne Indiana 46804 United States Details
Mission Cancer and Blood /ID# 262132 RECRUITING Des Moines Iowa 50309-1423 United States Details
Norton Cancer Institute - St Matthews /ID# 261076 RECRUITING Louisville Kentucky 40207 United States Details
American Oncology Partners of Maryland, PA /ID# 259476 RECRUITING Bethesda Maryland 20817 United States Details
St. Luke's Hospital - Chesterfield /ID# 260489 RECRUITING Chesterfield Missouri 63017 United States Details
Intermountain Health - St Vincent Regional Hospital - Cancer Centers of Montana /ID# 260006 RECRUITING Billings Montana 59102 United States Details
Toledo Clinic Cancer Center /ID# 260488 RECRUITING Toledo Ohio 43623 United States Details
Vista Oncology - East Olympia /ID# 261360 RECRUITING Olympia Washington 98506-5028 United States Details
Pan American Center for Oncology Trials, LLC /ID# 260265 RECRUITING Rio Piedras 00935 Puerto Rico Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field